Immunitor's proprietary technology enables us to formulate any vaccine as an oral pill which is easy to administer, has low manufacturing cost, stable, safe, and effective. IMMUNITOR LTD is a subsidiary of Company Immunitor Inc. Currently, Immunitor has GMP manufacturing capability in Thailand. Specific Immunity products are registered in several Asian and African countries. Immunitor has developed and currently manufactures seven products as means of preventing and/or treating viral infections such as HIV, hepatitis B and C, influenza, cancer, atherosclerosis/obesity, and a broad spectrum of bacterial, fungal infections.
| Website | http://immunitor.com |
| Revenue | $1 million |
| Employees | 6 (1 on RocketReach) |
| Founded | 2020 |
| Technologies |
JavaScript
,
PHP
,
Apache
+3 more
(view full list)
|
| Industry | Biotechnology Research, Manufacturing General, Biotechnology, Manufacturing, Science and Engineering, Pharmaceutical, Health Care, Therapeutics |
| Keywords | Vaccine Technology, Oral Drug Delivery, Pharmaceutical Technology, Vaccine Manufacturing, Drug Delivery Systems, Immunology Research, Vaccine Development, Pharmaceutical Research, Biotechnology, Health Technology, Medical Technology, Drug Development |
| Competitors | Johnson & Johnson, Roche, Novartis, Merck & Co., Inc., Sanofi, GSK, AstraZeneca, Bristol Myers Squibb, Moderna Therapeutics, Pfizer +32 more (view full list) |
| SIC | SIC Code 80 Companies, SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular IMMUNITOR Ltd. employee's phone or email?
The IMMUNITOR Ltd. annual revenue was $1 million in 2026.
Aldar Bourinbaiar is the CEO of IMMUNITOR Ltd..
1 people are employed at IMMUNITOR Ltd..
The NAICS codes for IMMUNITOR Ltd. are [32, 3254, 325].
The SIC codes for IMMUNITOR Ltd. are [80, 283, 28].